- Report
- May 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 284 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- September 2024
- 58 Pages
Asia Pacific
From €2781EUR$2,925USD£2,336GBP
€3090EUR$3,250USD£2,596GBP
- Report
- March 2024
- 580 Pages
Global
From €6650EUR$6,995USD£5,587GBP
- Report
- February 2024
- 468 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- October 2021
- 179 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- December 2023
- 353 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2024
- 67 Pages
Europe
From €2524EUR$2,655USD£2,120GBP
€2804EUR$2,950USD£2,356GBP
- Report
- January 2024
- 57 Pages
Asia Pacific
From €2524EUR$2,655USD£2,120GBP
€2804EUR$2,950USD£2,356GBP
- Report
- February 2024
- 109 Pages
Global
From €4235EUR$4,455USD£3,558GBP
€4706EUR$4,950USD£3,953GBP
- Report
- May 2023
- 180 Pages
Global
From €2614EUR$2,750USD£2,196GBP
€5229EUR$5,500USD£4,393GBP
- Report
- June 2023
- 155 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- March 2023
- 164 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- November 2023
- 200 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- September 2023
- 175 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- August 2024
- 80 Pages
Japan
From €3327EUR$3,500USD£2,795GBP
- Report
- April 2024
- 88 Pages
France
From €3327EUR$3,500USD£2,795GBP
- Report
- January 2024
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP

Epigenomics is a field of genomics that studies the regulation of gene expression through chemical modifications of DNA and its associated proteins. It focuses on the heritable changes in gene expression that occur without changes in the underlying DNA sequence. These modifications, known as epigenetic marks, are involved in a variety of biological processes, including development, aging, and disease.
Epigenomics research has been used to identify biomarkers for cancer diagnosis and prognosis, as well as to develop new therapeutic strategies. It has also been used to study the effects of environmental factors on gene expression, such as nutrition, stress, and exposure to toxins.
The epigenomics market is expected to grow significantly in the coming years, driven by increasing investments in research and development, technological advancements, and the growing prevalence of cancer and other diseases.
Some companies in the epigenomics market include Illumina, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, Merck KGaA, and Oxford Nanopore Technologies. Show Less Read more